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abstract
 
To examine a possible relation between the swelling-induced ATP release pathway and the volume-
sensitive Cl
 
2
 
 channel, we measured the extracellular concentration of ATP released upon osmotic swelling and
whole-cell volume-sensitive Cl
 
2
 
 currents in a human epithelial cell line, Intestine 407, which lacks expression of
cystic ﬁbrosis transmembrane conductance regulator (CFTR). Signiﬁcant release of ATP was observed within sev-
eral minutes after a hypotonic challenge (56–80% osmolality) by the luciferin/luciferase assay. A carboxylate ana-
logue Cl
 
2
 
 channel blocker, 5-nitro-2-(3-phenylpropylamino)-benzoate, suppressed ATP release in a concentration-
dependent manner with a half-maximal inhibition concentration of 6.3 
 
m
 
M. However, swelling-induced ATP re-
lease was not affected by a stilbene-derivative Cl
 
2
 
 channel blocker, 4-acetamido-4
 
9
 
-isothiocyanostilbene at 100 
 
m
 
M.
Glibenclamide (500 
 
m
 
M) and arachidonic acid (100 
 
m
 
M), which are known to block volume-sensitive outwardly
rectifying (VSOR) Cl
 
2
 
 channels, were also ineffective in inhibiting the swelling-induced ATP release. Gd
 
3
 
1
 
, a puta-
tive blocker of stretch-activated channels, inhibited swelling-induced ATP release in a concentration-dependent
manner, whereas the trivalent lanthanide failed to inhibit VSOR Cl
 
2
 
 currents. Upon osmotic swelling, the local
ATP concentration in the immediate vicinity of the cell surface was found to reach 
 
z
 
13 
 
m
 
M by a biosensor tech-
nique using P2X
 
2
 
 receptors expressed in PC12 cells. We have raised antibodies that inhibit swelling-induced ATP
release from Intestine 407 cells. Earlier treatment with the antibodies almost completely suppressed swelling-
induced ATP release, whereas the activity of VSOR Cl
 
2
 
 channel was not affected by pretreatment with the antibod-
ies. Taking the above results together, the following conclusions were reached: ﬁrst, in a CFTR-lacking human ep-
ithelial cell line, osmotic swelling induces ATP release and increases the cell surface ATP concentration over 10
 
m
 
M, which is high enough to stimulate purinergic receptors; second, the pathway of ATP release is distinct from
the pore of the volume-sensitive outwardly rectifying Cl
 
2
 
 channel; and third, the ATP release is not a prerequisite
to activation of the Cl
 
2
 
 channel.
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INTRODUCTION
 
Osmotic cell swelling leads to extrusion of a number of
intracellular inorganic and organic osmolytes, thereby
accomplishing the regulatory volume decrease (RVD)
 
1
 
(Lang, 1998; Okada, 1998). Recently, release of intra-
cellular ATP was found to be induced by osmotic swell-
ing in human (Hazama et al., 1998b; Taylor et al.,
1998), bovine (Mitchell et al., 1998), and mouse (Hazama
et al., 1998b) epithelial cells, as well as in rat hepatoma
cells (Wang et al., 1996; Roman et al., 1997). Since ATP
exists in the cytoplasm at millimolar concentrations,
opening of the large pore may induce a passive efﬂux
of ATP. Actually, it is known that a mitochondrial outer
membrane large-conductance voltage-dependent anion
channel is permeable to anionic ATP (Rostovtseva and
Colombini, 1997). However, the plasma membrane
ATP channel has not been identiﬁed.
Several studies have suggested that the cystic ﬁbrosis
transmembrane conductance regulator (CFTR) Cl
 
2
 
channel can act as an ATP-permeable channel (Reisin
et al., 1994; Schwiebert et al., 1995; Cantiello et al.,
1998). The CFTR-mediated ATP release hypothesis has
now been challenged by many contradictory reports
(Grygorczyk et al., 1996; Li et al., 1996; Reddy et al.,
1996; Grygorczyk and Hanrahan, 1997; Sugita et al.,
1998). On the other hand, swelling-activated Cl
 
2
 
 chan-
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nels are known to show considerable permeability to
large organic anions (Strange et al., 1996; Nilius et al.,
1997; Okada, 1997). Thus, it is possible that the vol-
ume-sensitive Cl
 
2
 
 channel may serve as a pathway for
ATP release. As proposed by Wang et al. (1996) and Ro-
man et al. (1997), there is the possibility that activation
of the volume-sensitive Cl
 
2
 
 channel is induced by re-
leased ATP through stimulation of P2 receptors. In the
present study, therefore, we addressed the question of
whether the volume-sensitive Cl
 
2
 
 channel serves the
pathway of swelling-induced ATP release or its activity is
a prerequisite to swelling-induced ATP release, and
whether activation of the volume-sensitive Cl
 
2
 
 channel
is dependent on swelling-induced ATP release in a hu-
man epithelial cell line that lacks CFTR expression.
 
MATERIALS AND METHODS
 
Cells
 
Human epithelial Intestine 407 cells were cultured in Fischers’
medium supplemented with 10% newborn calf serum, as de-
scribed previously (Hazama and Okada, 1988). For the lumino-
metric ATP measurements, the cells were plated on 48-well plas-
tic plates. The ATP assay was made at the density of 4 
 
3
 
 10
 
5
 
 cells
per well. For the biosensor ATP measurements, Intestine 407
cells were cultured on glass coverslips, and then transferred to
the experimental chamber. For the patch-clamp whole-cell re-
cordings, Intestine 407 cells were cultured in suspension with ag-
itation for 10–120 min, and then plated on the experimental
chamber. PC12 cells that express the P2X
 
2
 
 receptor channel were
cultured, as reported previously (Hazama et al., 1998a).
 
Luciferin/Luciferase ATP Assay
 
The extracellular bulk ATP concentration was measured by lu-
ciferin-luciferase luminometry using an AF-100 ATP analyzer and
AF-2L1 reagents (TOA Electronics). The culture medium was to-
tally replaced by 300 
 
m
 
l of isotonic PBS containing (mM): 137
NaCl, 2.7 KCl, 1 CaCl
 
2
 
, 1 MgCl
 
2
 
, 8.1 Na
 
2
 
HPO
 
4
 
, and 1.5 KH
 
2
 
PO
 
4
 
(pH 7.4, 300 mosmol/kg H
 
2
 
O). It is known that ATP release is
dramatically stimulated by mechanical stimulation, such as a me-
dium displacement and tilting the monolayer cells or touching to
the cells (Grygorczyk and Hanrahan, 1997; Watt et al., 1998).
Preliminary experiments showed that this is the case for Intestine
407 cells. However, ATP release induced by replacement of the
entire bathing solution subsided to the background level after
30–60 min. Also, mechanical ATP release was found to be
avoided by gentle replacement of one third to one half of the so-
lution by a new solution without touching and tilting the mono-
layer cells. Thus, after a 60-min equilibration, 100 
 
m
 
l of the extra-
cellular isotonic solution (300 
 
m
 
l) was collected as a control sam-
ple and the ATP concentration was measured. Then, 200 
 
m
 
l of
hypotonic solution was gently added to the remaining 200 
 
m
 
l of
isotonic solution to reduce the extracellular osmolality down to
the desired level (56% osmolality, unless indicated). The hypo-
tonic solutions were prepared by mixing the isotonic PBS with a
solution containing 5 mM KCl, 1 mM MgCl
 
2
 
, 1 mM CaCl
 
2
 
, and 10
mM HEPES/NaOH (pH 7.4, 35 mosmol/kg H
 
2
 
O). The test sam-
ples (100 
 
m
 
l) were collected after incubation for the indicated
times (usually 15 min) at 37
 
8
 
C and the ATP concentration was
measured at room temperature (24–26
 
8
 
C). When necessary, ex-
tracellular CaCl
 
2
 
 was removed and 0.1 mM EGTA was added dur-
 
ing a hypotonic challenge. The effects of Cl
 
2
 
 channel blockers
were observed by adding the drug to the hypotonic solution.
Only glibenclamide (500 
 
m
 
M) among the employed drugs was
found to suppress (by 20–25%) the luciferase detection of ATP,
as reported previously (Taylor et al., 1998). Thus, the data of glib-
enclamide effect were corrected by the calibration curve obtained
by reactions with known amounts of ATP added to cell-free iso-
tonic or hypotonic solution with or without 500 
 
m
 
M glibencla-
mide. The effect of pretreatment with antibodies was observed
after incubating in the isotonic solution supplemented with 12.5
 
m
 
g/ml antibodies for 60 min, and then applying the hypotonic
solution in the absence of antibodies.
 
Cell Viability Assay
 
After incubating Intestine 407 cells in the above isotonic or hypo-
tonic solution for 30 min at 37
 
8
 
C, cell viability was assessed by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT) assay (Mossman, 1983) using the Cell Counting Kit
(Dojindo) according to the manufacturer’s instructions. This
method is based on the ability of viable (but not dead) cells to
cleave the tetrazolium ring of the MTT into a dark blue forma-
zan reaction product.
 
Biosensor ATP Assay
 
The local concentration of released ATP at the single cell surface
was measured by a biosensor technique on single Intestine 407
cells, using PC12 cells expressing ligand-gated cation channels,
P2X
 
2
 
 receptors, as described previously (Hazama et al., 1998a).
In brief, after attaining the whole-cell conﬁguration with a PC12
cell, the cell was lightly attached to the surface of an Intestine
407 cell under a microscope. The whole-cell currents were re-
corded at a holding potential of 
 
2
 
50 mV using an Axopatch
200A ampliﬁer (Axon Instruments) at room temperature. From
the whole-cell current density thus recorded, the local ATP con-
centration was estimated by the calibration curve obtained by the
response of PC12 cells alone to known amounts of ATP, as de-
scribed previously (Hazama et al., 1998a). To apply hypotonic
stimulation, the bathing solution was changed from isotonic to
hypotonic solution by perfusion. The isotonic solution contained
(mM): 100 NaCl, 4.2 KCl, 100 mannitol, 8 HEPES, 6 HEPES-Na,
1 CaCl
 
2
 
, and 1 MgCl
 
2
 
 (320 mosml/kg H
 
2
 
O, pH 7.4). The hypo-
tonic solution (220 mosml/kg H
 
2
 
O, pH 7.4) was prepared by re-
moving mannitol from the isotonic solution. The pipette (intra-
cellular) solution was composed of (mM): 150 CsCl, 1 MgCl
 
2
 
, 10
EGTA, and 10 HEPES (280 mosml/kg H
 
2
 
O, pH 7.4 with CsOH).
 
Whole-Cell Cl
 
2
 
 Current Measurements
 
Volume-sensitive Cl
 
2
 
 channel currents were recorded by the
whole-cell patch clamp technique, as reported previously (Liu et
al., 1998). The time course of current activation and recovery
was monitored by repetitively applying alternating step pulses of
 
6
 
40 mV (2-s duration) from a holding potential of 0 mV. To
monitor the voltage dependence of the current, stepping pulses
(2-s duration) were sometimes applied from a prepotential at
 
2
 
100 mV (0.6-s duration) to test potentials of 
 
2
 
80 to 
 
1
 
100 mV
in 20-mV increments. Currents were recorded using an Axopatch
200A ampliﬁer, ﬁltered at 1 kHz and digitized at 4 kHz. Cs-rich
solutions were employed. Isotonic CsCl bathing solution con-
tained (mM): 110 CsCl, 10 HEPES, 8 Tris, 5 MgSO
 
4
 
, and 100
mannitol (320 mosml/kg H
 
2
 
O, pH 7.5). Cell swelling was in-
duced by hypotonic (260 mosml/kg H
 
2
 
O) CsCl solution in which
mannitol was reduced to 40 mM. The pipette (intracellular) CsCl
solution contained (mM): 110 CsCl, 2 MgSO
 
4
 
, 1 Na
 
2
 
ATP, 15 Na- 
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HEPES, 10 HEPES, 1 EGTA, and 50 mannitol (290 mosml/kg
H
 
2
 
O, pH 7.3).
 
Antibody Production
 
Since the molecular pathway for swelling-induced ATP release
has not as yet been identiﬁed, we attempted to produce antibod-
ies against unidentiﬁed extracellular epitopes of plasma mem-
brane–associated protein involved in swelling-induced ATP re-
lease. Monoclonal antibodies were obtained according to the
method described elsewhere (Tsukita et al., 1989). In brief,
BALB/c mice were immunized with 10
 
6
 
 Intestine 407 cells. Pe-
ripheral lymphocytes were fused with myeloma NS-1 cells using
50% polyethylene glycol (PEG 4000). The supernatant from the
resulting hybridoma cells was screened to ﬁnd colonies that had
inhibitory effects on ATP release from swollen Intestine 407
cells. The wells that showed positive activity (15 of 288 wells)
were immediately expanded and plated in 98-well plates. Positive
colonies were found in 12 of 1,470 wells. The positive hybridoma
cells were injected to the mice to produce ascites culture. One of
these, termed H2D2-5, was employed for the present experi-
ments after puriﬁcation by using the E-Z-SEP™
 
 
 
antibody puriﬁca-
tion reagent (Pharmacia Fine Chemicals). By Western blot analy-
sis using the anti–ATP release antibodies, no speciﬁc antigen was
detected as a single band (data not shown). Afﬁnity-puriﬁed
mouse IgG (Zymed Laboratories) was used as a negative control.
 
Chemicals
 
The following agents were added to bathing solutions: 0.1 mg/
ml apyrase, 10–30 
 
m
 
M 5-nitro-2-(3-phenylpropylamino)-benzoate
(NPPB), 100 
 
m
 
M 4-acetamido-4
 
9
 
-isothiocyanostilbene (SITS),
500 
 
m
 
M glibenclamide, 100 
 
m
 
M arachidonic acid, and 5–30 
 
m
 
M
GdCl
 
3
 
.
Data are given as means 
 
6
 
 SEM of observations (
 
n
 
). Statistical
differences of the data were evaluated by paired or unpaired Stu-
dent’s 
 
t
 
 test and considered signiﬁcant at
 
 P 
 
, 
 
0.05.
 
RESULTS
 
Swelling-induced ATP Release
 
Luminometric ATP assay showed that Intestine 407 cells
respond to a hypotonic challenge not only with cell
swelling but also with signiﬁcant release of ATP. The
swelling-induced ATP release was found to start within a
minute and continued for over 10 min (Fig. 1 A). From
the results collected at 1 min after a hypotonic chal-
 
lenge, the initial rate of swelling-induced ATP release
from a single Intestine 407 is estimated to be 
 
z
 
2,500
ATP molecules/s under the assumption that degrada-
tion or reuptake of released ATP was negligible.
ATP release increased with decreasing extracellular
osmolality (Fig. 1 B).
The cell viability was not essentially affected by the
hypotonic challenge (Fig. 1 C).
The mean values of bulk ATP concentration in 400
 
m
 
l ambient solutions of 4 
 
3
 
 10
 
5
 
 cells were 0.47 
 
6
 
 0.08
nM (
 
n
 
 5 
 
39) after a 60-min exposure to isotonic solu-
tion and 2.63 
 
6
 
 0.44 nM (
 
n
 
 5 
 
53) after a 15-min expo-
sure to hypotonic (56% osmolality) solution. The mean
rate of ATP release from a single Intestine 407 cell dur-
ing a 15-min exposure to a hypotonic solution is esti-
mated to be 
 
z
 
1,700 ATP molecules/s, and that during
a 60-min exposure to isotonic solution is 
 
z
 
60/s.
A biosensor ATP assay method (Hazama et al.,
1998a) was employed to assess the ATP concentration
at the outer surface of swollen Intestine 407 cells. Hy-
potonic stimulation failed to evoke currents in PC12
cell alone (data not shown,
 
 n 
 
5 
 
11). However, when a
voltage-clamped PC12 cell was placed close to an Intes-
tine 407 cell, a series of spiky and sustained inward cur-
rents were induced within several minutes after expo-
sure to hypotonic solution (69%) at room temperature
(Fig. 2 A). ATP release was found to be always coupled
to cell swelling under a microscope. In the presence of
an ATP-hydrolyzing enzyme, apyrase, in contrast, the
inward current response to hypotonic challenge was
virtually abolished, as shown in Fig. 2 B. In the absence
of apyrase, the average peak response was 7.9 
 
6
 
 1.2
pA/pF (
 
n
 
 5 
 
20), which corresponds to 13.1 
 
m
 
M ATP
on a calibration curve of ATP-induced PC12 responses
(Fig. 2
 
 
 
C).
Effects of Cl2 Channel Blockers on Swelling-induced ATP 
Release and Cl2 Currents
A possible relation of swelling-induced ATP release
with the activity of volume-sensitive Cl2 channel was in-
Figure 1. Swelling-induced
ATP release without cell lysis. (A)
The time course of ATP release
detected by the luminometric as-
say from 4 3 105 Intestine 407
cells after exposure to hypotonic
solution (56%, j) or isotonic so-
lution (h). The symbols repre-
sent the mean values of six obser-
vations with the SEM (bars). Hy-
potonic data are statistically
different (P , 0.01) from iso-
tonic data (except at zero time). (B) Dependence of ATP release on extracellular osmolality. The data obtained 15 min after exposure to
solutions with given osmolality. The data represent the mean values of ﬁve observations with the SEM (bars). Data at 210 and 180 mosmol/
kg H2O are statistically different (P , 0.01) from those at 300 mosmol/kg H2O. (C) Cell viability assessed at 30 min after exposure to hypo-
tonic (black column) and isotonic (white column) solution. The data are the mean values of 10 observations with the SEM (bars).528 Swelling-activated ATP Release and Cl Channel
vestigated by applying a high concentration of Cl2
channel blockers. Luminometric ATP assay showed
that swelling-induced ATP release was not blocked by
100 mM SITS (Fig. 3), as found previously (Hazama et
al., 1998b). Glibenclamide and arachidonic acid were
also ineffective at the concentrations by which volume-
sensitive Cl2 channel currents are known to be almost
completely abolished in Intestine 407 cells (Kubo and
Okada, 1992; Liu et al., 1998). Glibenclamide insensi-
tivity is in good agreement with a previous observation
of swelling-induced ATP release from rabbit ciliary epi-
thelial cells (Mitchell et al., 1998), but is in contrast to
those of mechanical stress–induced ATP release from
rabbit red blood cells (Sprague et al., 1998) or Ehrlich
ascites tumor cells (Pedersen et al., 1999) and cAMP-
activated ATP release from CFTR-expressing human
epithelial cells (Schwiebert et al., 1995).
Since swelling-induced ATP release was reported to
be largely inhibited by a Cl2 channel blocker, NPPB, in
rabbit ocular ciliary epithelial cells at 100 mM (Mitchell
et al., 1998), we then examined the NPPB effect. As
shown in Fig. 4 A, NPPB was found to inhibit ATP re-
lease from swollen Intestine 407 cells at lower concen-
trations. The concentration required for 50% inhibi-
tion (IC50) was 6.3 6 0.3 mM (Fig. 4 B, h).
Cell swelling activated outwardly rectifying whole-cell
Cl2 currents in Intestine 407 cells, and this volume-sen-
sitive outwardly rectifying (VSOR) Cl2 current was in-
hibited by NPPB, as reported previously (Kubo and
Okada, 1992). The IC50 value for Cl2 current inhibition
was 16.0 6 0.2 mM (Fig. 4 B, j), which is signiﬁcantly
different from that for ATP release inhibition (0.01 ,
P , 0.05).
These results suggest that swelling-induced ATP re-
lease is independent of the activity of volume-sensitive
outwardly rectifying Cl2 channels in Intestine 407 cells.
Effects of Gadolinium on Swelling-induced ATP Release and 
Cl2 Currents
Recently, Taylor et al. (1998) showed that swelling-induced
ATP release from human airway epithelial cells was in-
Figure 2. Cell surface release of ATP upon osmotic swelling de-
tected by the biosensor technique. (A) Representative trace of
control records from PC12 cells placed close to an Intestine 407
cell in response to a hypotonic challenge. (B) Representative trace
of the current response to a hypotonic challenge in the presence
of 0.1 mg/ml apyrase in the bath solution. A similar result was ob-
tained from four cells. (C) Concentration–response curve of the
ATP-induced currents in PC12 cells. Each symbol represents the
mean peak current density of 4–13 observations (with SEM, verti-
cal bar) in response to application of a single puff of ATP. The
mean input capacitance of PC12 cells employed in these experi-
ments was 14.5 6 0.99 pF (n 5 32).
Figure 3. Effects of blockers for volume-sensitive Cl2 channels on
swelling-induced ATP release detected by the luminometric tech-
nique. Swelling-induced ATP release in the absence of blockers is
not statistically different from those in the presence of SITS (P 5
0.90), glibenclamide (P 5 0.98), and arachidonic acid (P 5 0.91).529 Hazama et al. 
hibited by a trivalent lanthanide, Gd31, which is the
most commonly used blocker of mechanogated ion
channels (Hamill and McBride, 1996). Luciferin/lu-
ciferase ATP assay showed that ATP release from swol-
len human epithelial Intestine 407 cells was also sensi-
tive to Gd31 (Fig. 5). The Gd31 effect was concentration
dependent, with IC50 of z10 mM. Since Intestine 407
cells are known to have Gd31-sensitive, stretch-acti-
vated, Ca21-permeable cation channels (Okada et al.,
1990), there is a possibility that the Gd31 effect on ATP
release had been mediated by the inhibiting effect on
Ca21 inﬂux through this stretch-activated cation chan-
nel. However, swelling-activated ATP release was not
inhibited, but rather enhanced [from 1.18 6 0.12 nM
(n 5 11) to 3.02 6 0.27 nM (n 5 20); P 5 0.000002], by
Ca21 removal from the extracellular solution. A similar
enhancing effect of Ca21 removal was previously observed
on cAMP-activated ATP release from CFTR-expressing
cells and was explained by a cofactor role of extracellu-
lar Ca21 for ecto-ATPase activation (Prat et al., 1996).
Gd31 (30 mM) also inhibited swelling-activated ATP re-
lease in the Ca21-free conditions [to 1.80 6 0.39 nM (n 5
19); P 5 0.014].
The effect of Gd31 on the volume-sensitive Cl2 cur-
rent was then examined in Intestine 407 cells. Gd31 (30
mM), which was applied 10–20 min before and during
hypotonic challenge, failed to affect swelling-induced
activation of the Cl2 current (Fig. 6 A, left). Neither
time- and voltage-dependent inactivation kinetics (Fig.
6 A, right) nor outwardly rectifying current–voltage re-
lation (Fig. 6 B) was affected by Gd31.
These results clearly indicate that the activity of vol-
ume-sensitive outwardly rectifying Cl2 channels is to-
tally independent of the swelling-induced ATP release
in Intestine 407 cells.
Effects of Antibodies on Swelling-induced ATP Release and 
Cl2 Currents
To assess the molecular nature of swelling-induced ATP
release pathway, we raised antibodies that can block
ATP release upon osmotic swelling in Intestine 407
cells. As summarized in Fig. 7, pretreatment with the
H2D2-5 antibodies at 12.5 mg/ml for 60 min markedly
Figure 4. Concentration-dependent effects of NPPB on swelling-
induced ATP release detected by the luminometric assay and on
whole-cell volume-sensitive outwardly rectifying Cl2 currents. (A)
Concentration–inhibition curves of NPPB for ATP release under
hypotonic (d) and isotonic (s) conditions. (Symbols) Means 6
SEM; n 5 10–26 experiments. Inhibitory effects of 10, 20, and 30
mM NPPB on hypotonic ATP release were statistically signiﬁcant at
P 5 0.0038, 0.0006, and 0.0003, respectively, and those of 10 and
30 mM NPPB on isotonic ATP release were at P 5 0.0017 and
0.0195, respectively. (B) Logarithmic concentration–inhibition
curves of NPPB for swelling-induced ATP release (h) and VSOR
Cl2 currents at 260 mV (j). (Symbols) Means 6 SEM; n 5 4–11
experiments.
Figure 5. Concentration-dependent effects of Gd31 on swelling-
induced ATP release detected by the luminometric assay. (d and
s) Mean data under hypotonic and isotonic conditions, respec-
tively, of 12–30 experiments. Bars represent the SEM. Inhibitory
effects of 10 and 30 mM Gd31 were statistically signiﬁcant at P 5
0.0276 and P 5 0.0001, respectively.530 Swelling-activated ATP Release and Cl Channel
inhibited swelling-induced ATP release and slightly
suppressed basal background ATP release. In contrast,
mouse IgG failed to affect signiﬁcantly the ATP release.
Similar inhibiting effects were also obtained by pre-
treatment with the antibodies at 25 mg/ml for 30 min
(data not shown, n 5 13).
As shown in Fig. 8, VSOR Cl2 currents were not sig-
niﬁcantly affected by pretreatment with H2D2-5 anti-
bodies (25 mg/ml, 30–50 min). The mean peak current
densities with pretreatment with the antibodies (n 5 9)
and the negative control IgG (n 5 10) were 274.3 6
32.6 and 281.4 6 46.1 pA/pF (P 5 0.45) at 160 mV
and 166.1 6 20.7 and 165.8 6 28.0 pA/pF (P 5 0.25) at
260 mV, respectively.
These results also show that the swelling-induced ATP
release is not a prerequisite to activation of the volume-
sensitive Cl2 channel in Intestine 407 cells. Also, it is
likely that the swelling-induced ATP release pathway is
distinct from the pore of volume-sensitive outwardly rec-
tifying Cl2 channels in the human epithelial cell line.
DISCUSSION
Extracellular ATP at low micromolar concentrations is
known to inﬂuence activities in a number of muscular
and neuronal cells as well as platelets (Gordon, 1986).
Recently, ATP release has been found to be induced by
stimulation with cAMP (Schwiebert et al., 1995; Prat et
al., 1996; Jiang et al., 1998), by removing extracellular
Cl2 (Rotoli et al., 1996), by mechanical perturbation
(Grygorczyk and Hanrahan, 1997; Sprague et al., 1998;
Watt et al., 1998; Pedersen et al., 1999), and by osmotic
perturbation (Wang et al., 1996; Mitchell et al., 1998;
Taylor et al., 1998) in nonneuronal, nonmuscular cells.
CFTR was reported to be associated with ATP release
induced by these maneuvers by some investigators
(Schwiebert et al., 1995; Prat et al., 1996; Rotoli et al.,
Figure 6. Effects of 30 mM Gd31 on whole-cell volume-sensitive
Cl2 currents recorded from swollen Intestine 407 cells. (A) Repre-
sentative records from a control cell (top) and a cell pretreated
with Gd31 (bottom) during application of alternating pulses from
0 6 40 mV or of step pulses from 2100 to 1100 mV in 20-mV in-
crements (*). *Gain of chart recorder was changed by 40%.
(Right) Expanded traces of current responses to step pulses (at *).
(B) Current–voltage relationships without (s) and with (d) Gd31
pretreatment. (Symbols) Means 6 SEM; n 5 8. Effects of pretreat-
ment with Gd31 on current densities are not statistically signiﬁcant
(P . 0.05).
Figure 7. Effects of 60-min pre-
treatment with anti–ATP release
antibodies (H2D2-5) and mouse
IgG on the basal (isotonic) ATP
release and swelling-induced (hy-
potonic) ATP release detected by
the luminometric assay. The con-
centration of antibodies or IgG
was 12.5 mg/ml. The data with
H2D2-5 were signiﬁcantly differ-
ent from the control data (P 5
0.006 for isotonic release and P 5
0.00006 for hypotonic release),
whereas those with IgG were not
(P 5 0.59 and 0.37 for isotonic
and hypotonic release, respec-
tively).531 Hazama et al. 
1996; Jiang et al., 1998; Sprague et al., 1998; Taylor et
al., 1998). However, the pore properties of the CFTR
Cl2 channel and the ATP channel were found to be dis-
tinct (Sugita et al., 1998). Other investigators showed
that the ATP release is not speciﬁcally associated with
CFTR (Takahashi et al., 1994; Grygorczyk et al., 1996;
Li et al., 1996; Reddy et al., 1996; Grygorczyk and Han-
rahan, 1997; Mitchell et al., 1998). The present study
demonstrated that reduction of extracellular osmolality
can induce ATP release in a dose-dependent manner
(Fig. 1 B) in a human epithelial cell line that lacks
CFTR expression (Hazama et al., 1998b). The possibil-
ity that ATP release induced by hypotonic perturbation
was an artifact of cell lysis or damage could be ruled
out because (a) a hypotonic challenge did not essen-
tially affect the cell viability (Fig. 1 C), and moreover,
(b) the swelling-induced ATP release could be inhib-
ited by NPPB (Fig. 4), Gd31 (Fig. 5), and anti–ATP-
release antibodies (Fig. 7).
Upon swelling-induced ATP release, the extracellular
ATP concentration in the immediate vicinity of the
outer cell surface was found to reach 13 mM (Fig. 2).
This value would be an underestimate because most
cells express ecto-nucleotidases that rapidly hydrolyze
ATP present at the cell surface (Plesner, 1995). This
concentration is much higher than that needed to stim-
ulate P2-purinergic receptors (.10 nM; Dubyak and El-
Moatassim, 1993). Since Intestine 407 cells have puri-
nergic receptors (Yada et al., 1989), it is possible that
released ATP has some biological functions.
There have been two pieces of evidence that extracel-
lular ATP is involved in the RVD after osmotic swelling:
(a) addition of ATP to the bathing solution facilitates
RVD in Intestine 407 cells (Tsumura et al., 1998), and
(b) removal of released ATP with apyrase retards RVD
in rat hepatoma cells (Wang et al., 1996; Roman et al.,
1997) and Intestine 407 cells (Maeno, E., and Y. Okada,
unpublished observations). This ATP action would be
mediated by stimulation of P2-purinergic receptors be-
cause a blocker of the receptor, suramin, inhibited
RVD in both cell species (Wang et al., 1996; Roman et
al., 1997; Tsumura et al., 1998).
Roman et al. (1997) and Wang et al. (1996) proposed
the hypothesis that the released ATP is involved in acti-
vation or upregulation of volume-sensitive Cl2 chan-
nels, which are associated with Cl2 efﬂux during RVD,
in rat hepatoma cells. However, addition of extracellu-
lar ATP did not activate inward Cl2 currents (Cl2 ef-
ﬂux), but inhibited outward Cl2 currents (Cl2 inﬂux)
under hypotonic conditions in human epithelial Intes-
tine 407 cells (Tsumura et al., 1996) and rat glioma C6
cells (Jackson and Strange, 1995). Furthermore, the
present study showed that Gd31 (30 mM) virtually abol-
ished swelling-induced ATP release (Fig. 5) without af-
fecting activation of swelling-induced VSOR Cl2 cur-
rents in Intestine 407 cells (Fig. 6). In addition, even
when the ATP release had been blocked by anti–ATP
release antibodies (Fig. 7), the activity of the VSOR Cl2
channel was normally induced upon osmotic swelling
(Fig. 8). In Intestine 407 cells, therefore, it appears that
ATP released upon osmotic swelling facilitates RVD by
a mechanism other than activation of volume-sensitive,
outwardly rectifying Cl2 channels or regulation of the
volume-regulatory Cl2 efﬂux. Intestine 407 cells are
known to respond to extracellular ATP with an increase
in cytosolic Ca21 and Ca21-activated K1 conductance
(Yada et al., 1989). Ca21-activated K1 conductance was
shown to be responsible for volume-regulatory K1 ef-
ﬂux during RVD of Intestine 407 cells (Hazama and
Okada, 1988). Taken together, it can be speculated that
swelling-induced ATP release brings about autocrine
stimulation of Ca21-activated K1 efﬂux by stimulation
of purinergic receptors, thereby facilitating RVD.
The route of swelling-induced ATP release is not yet
identiﬁed, although some investigators have suggested
that CFTR (Reisin et al., 1994; Schwiebert et al., 1995;
Cantiello et al., 1998) and MDR1 (Abraham et al.,
1993) are involved in the route. The involvement of
CFTR can be excluded in the present study because In-
testine 407 cells lack expression of CFTR (Hazama et
al., 1998b) and failed to respond with ATP release to
stimulation with 1 mM dibutyryl cyclic AMP (Tanaka,
S., and Okada, Y., unpublished observations). In fact, a
blocker of CFTR Cl2 channel, glibenclamide, failed to
suppress swelling-induced ATP release in the present
study (Fig. 3). Since Intestine 407 cells are known to ex-
press MDR1 (Tominaga et al., 1995), the involvement
Figure 8. Effects of pretreatment with anti–ATP release antibod-
ies on whole-cell volume-sensitive Cl2 currents from swollen Intes-
tine 407 cells. The representative records after 45-min treatment
with 25 mg/ml mouse IgG (left) and H2D-25 antibodies (right).
*The pulse protocols were the same as those in Fig. 6. Gain of
chart recorder was changed by 40%. (Bottom) Expanded traces of
current responses to step pulses (at *).532 Swelling-activated ATP Release and Cl Channel
of MDR1 in swelling-induced ATP release seems possi-
ble. However, the transporter function of P-glycopro-
tein, the product of the MDR1 gene, has recently been
shown to be inhibited by glibenclamide (Golstein et al.,
1999). Also, our recent studies have demonstrated that
osmotic swelling induced ATP release to an essentially
similar degree in both human epidermoid KB cells
lacking MDR1 expression (KB-3-1) and a MDR1-trans-
fected KB cell line (KB-G2) (Hazama, A., and Y. Okada,
unpublished observations).
It seems unlikely that the pore of the volume-sensi-
tive outwardly rectifying Cl2 channel can provide a
pathway of swelling-induced ATP release in human epi-
thelial Intestine 407 cells because: (a) blockers of the
Cl2 channel, SITS, arachidonate and glibenclamide,
did not abolish swelling-induced ATP release (Fig. 3),
(b) a potent blocker of swelling-induced ATP release,
Gd31, did not inhibit the Cl2 currents (Fig. 6), and (c)
antibodies that inhibit swelling-induced ATP release
never affected the Cl2 currents (Fig. 8). However, the
possibility remains that the ATP release represents an
ATP efﬂux through ATP-permeable anion channels
that can be activated by cell swelling, but is distinct
from the volume-sensitive outwardly rectifying Cl2
channel. Since the rate of swelling-induced ATP release
seems very low (on the order of 103 s21 per cell) com-
pared with the transporting rate of many types of ion
channels (106–108 s21 per channel), it is also possible
that the ATP release is mediated by transporter or exo-
cytosis, but not by ATP-selective channels.
The authors are grateful to A.F. James (King’s College, London) for reading the manuscript, to S. Morishima for discussion,
and to A. Miwa, M. Ohara, A. Hattori, and K. Shigemoto for technical assistance.
This work was supported in part by a Grant-in-Aid for Scientiﬁc Research on Priority Areas of “ABC Proteins” from the Min-
istry of Education, Science and Culture of Japan.
Submitted: 20 May 1999 Revised: 9 August 1999 Accepted: 10 August 1999
REFERENCES
Abraham, E.H., A.G. Prat, L. Gerveck, T. Seneveratne, R.J. Arceci,
R. Kramer, G. Guidotti, and H.F. Cantiello. 1993. The multidrug
resistance (mdr1) gene product functions as an ATP channel.
Proc. Natl. Acad. Sci. USA. 90:312–316.
Cantiello, H.F., G.R. Jackson, Jr., C.F. Grosman, A.G. Prat, S.C. Bor-
kan, Y. Wang, I.L. Reisin, C.R. O’Riordan, and F.A. Ausiello.
1998. Electrodiffusional ATP movement through the cystic ﬁbro-
sis transmembrane conductance regulator. Am. J. Physiol. 274:
C799–C809.
Dubyak, G.R., and C. El-Moatassim. 1993. Signal transduction via
P2-purinergic receptors for extracellular ATP and other nucle-
otides. Am. J. Physiol. 265:C577–C606.
Golstein, P.E., A. Boom, J. van Geffel, P. Jacobs, B. Masereel, and R.
Beauwens. 1999. P-glycoprotein inhibition by glibenclamide and
related compounds. Pﬂügers Arch. 437:652–660.
Gordon, J.L. 1986. Extracellular ATP: effects, sources and fate. Bio-
chem. J. 33:309–319.
Grygorczyk, R., and J.W. Hanrahan. 1997. CFTR-independent ATP
release from epithelial cells triggered by mechanical stimuli. Am.
J. Physiol. 272:C1058–C1066.
Grygorczyk, R., J.A. Tabcharani, and J.W. Hanrahan. 1996. CFTR
channels expressed in CHO cells do not have detectable ATP
conductance. J. Membr. Biol. 151:139–148.
Hamill, O., and D.W. McBride. 1996. The pharmacology of mecha-
nogated membrane ion channels. Pharmacol. Rev. 48:231–252.
Hazama, A., S. Hayashi, and Y. Okada. 1998a. Cell surface measure-
ments of ATP release from single pancreatic b cells using a novel
biosensor technique. Pﬂügers Arch. 437:31–35.
Hazama, A., A. Miwa, T. Miyoshi, T. Shimizu, and Y. Okada. 1998b.
ATP release from swollen or CFTR-expressing epithelial cells. In
Cell Volume Regulation: The Molecular Mechanism and Volume
Sensing Machinery. Y. Okada, editor. Elsevier, Amsterdam, The
Netherlands. 93–98.
Hazama, A., and Y. Okada. 1988. Ca21 sensitivity of volume-regula-
tory K1 and Cl2 channels in cultured human epithelial cells. J.
Physiol. 402:687–702.
Jackson, P.S., and K. Strange. 1995. Characterization of the voltage-
dependent properties of a volume-sensitive anion conductance.
J. Gen. Physiol. 105:661–677.
Jiang, Q., D. Mak, S. Devidas, E.M. Schwiebert, A. Bragin, Y. Zhang,
W.R. Skach, W.B. Guggino, J.K. Foskett, and J.F. Engelhardt.
1998. Cystic ﬁbrosis transmembrane conductance regulator–
associated ATP release is controlled by a chloride sensor. J. Cell
Biol. 143:645–657.
Kubo, M., and Y. Okada. 1992. Volume-regulatory Cl2 channel cur-
rents in cultured human epithelial cells. J. Physiol. 456:351–371.
Lang, F. 1998. Cell Volume Regulation. S. Karger AG, Basel, Swit-
zerland. 264 pp.
Li, C., M. Ramjeesingh, and C.E. Bear. 1996. Puriﬁed cystic ﬁbrosis
transmembrane conductance regulator (CFTR) does not func-
tion as an ATP channel. J. Biol. Chem. 271:11623–11626.
Liu, Y., S. Oiki, T. Tsumura, T. Shimizu, and Y. Okada. 1998. Glib-
enclamide blocks volume-sensitive Cl2 channels by dual mecha-
nisms. Am. J. Physiol. 275:C343–C351.
Mitchell, C.H., D.A. Carre, A.M. Mcglinn, R.A. Stone, and M.M. Ci-
van. 1998. A release mechanism for stored ATP in ocular ciliary
epithelial cells. Proc. Natl. Acad. Sci. USA. 95:7174–7178.
Mossman, T. 1983. A rapid colorimetric assay for cellular growth
and survival: application to proliferation and cytotoxicity assays.
J. Immunol. Methods. 65:55–63.
Nilius, B., J. Eggermont, T. Voets, G. Buyse, V. Manolopoulos, and
G. Droogmans. 1997. Properties of volume-regulated anion
channels in mammalian cells. Prog. Biophys. Mol. Biol. 68:69–119.
Okada, Y. 1997. Volume expansion-sensing outward-rectiﬁer Cl2
channel: fresh start to the molecular identity and volume sensor.
Am. J. Physiol. 273:C755–C789.
Okada, Y. 1998. Cell Volume Regulation: The Molecular Mecha-
nism and Volume Sensing Machinery. Elsevier, Amsterdam, The
Netherlands. 214 pp.
Okada, Y., A. Hazama, and W.-L. Yuan. 1990. Stretch-induced acti-
vation of Ca21-permeable ion channels is involved in the volume
regulation of hypotonically swollen epithelial cells. Neurosci. Res.
12:S5–S13.
Pedersen, S., S.F. Pedersen, B. Nilius, I.H. Lambert, and E.K. Hoff-533 Hazama et al. 
mann. 1999. Mechanical stress induces release of ATP from Ehr-
lich ascites tumor cells. Biochim. Biophys. Acta. 1416:271–284.
Plesner, L. 1995. Ecto-ATPase: identities and functions. Int. Rev. Cy-
tol. 158:141–214.
Prat, A.G., I.L. Reisin, D.A. Ausiello, and H.F. Cantiello. 1996. Cel-
lular ATP release by the cystic ﬁbrosis transmembrane conduc-
tance regulator. Am. J. Physiol. 270:C538–C545.
Reddy, M.M., P.M. Quinton, C. Haws, J.J. Wine, R. Grygorczyk, J.A.
Tabcharani, J.W. Hanrahan, K.L. Gunderson, and R.R. Kopito.
1996. Failure of the cystic ﬁbrosis transmembrane conductance
regulator to conduct ATP. Science. 271:1876–1879.
Reisin, I.L., A.G. Prat, E.H. Abraham, J.F. Amara, R.J. Grygory, D.A.
Ausiello, and H.F. Cantiello. 1994. The cystic ﬁbrosis transmem-
brane conductance regulator is a dual ATP and chloride chan-
nel. J. Biol. Chem. 269:20584–20591.
Roman, R.M., Y. Wang, S.D. Lidofsky, A.P. Feranchak, N. Lomri,
B.F. Scharschmidt, and J.G. Fitz. 1997. Hepatocellular ATP-bind-
ing cassette protein expression enhances ATP release and auto-
crine regulation of cell volume. J. Biol. Chem. 272:21970–21976.
Rostovtseva, T., and M. Colombini. 1997. VDAC channels mediate
and gate the ﬂow of ATP: implications for the regulation of mito-
chondrial function. Biophys. J. 72:1954–1962.
Rotoli, B.M., O. Bussolati, V. Dall’Asta, E.K. Hoffmann, G. Cabrini,
and G.C. Gazzola. 1996. CFTR expression in C127 cells is associ-
ated with enhanced cell shrinkage and ATP extrusion in Cl2-free
medium. Biochem. Biophys. Res. Commun. 227:755–761.
Schwiebert, E.K., M.E. Egan, T.-H. Hwang, S.B. Fulmer, S.S. Allen,
G.R. Cutting, and W.B. Guggino. 1995. CFTR regulates out-
wardly rectifying chloride channels through an autocrine mecha-
nism involving ATP. Cell. 81:1063–1073.
Sprague, R.S., M.L. Ellsworth, A.H. Stephenson, M.E. Kleinhenz,
and A.J. Lonigro. 1998. Deformation-induced ATP release from
red blood cells requires CFTR activity. Am. J. Physiol. 275:H1726–
H1732.
Strange, K., F. Emma, and P.S. Jackson. 1996. Cellular and molecu-
lar physiology of volume-sensitive anion channels. Am. J. Physiol.
270:C711–C730.
Sugita, M., Y. Yue, and J.K. Foskett. 1998. CFTR Cl2 channel and
CFTR-associated ATP channel: distinct pores regulated by com-
mon gates. EMBO (Eur. Mol. Biol. Organ.) J. 17:898–908.
Takahashi, T., K. Matsushita, M.J. Welsh, and J.S. Stokes. 1994. Ef-
fect of cAMP on intracellular and extracellular ATP content of
Cl2-secreting epithelia and 3T3 ﬁbroblasts. J. Biol. Chem. 269:
17853–17857.
Taylor, A.L., B.A. Kudlow, K.L. Marrs, D.C. Gruenert, W.B. Guggino,
and E.M. Schwiebert. 1998. Bioluminescence detection of ATP
release mechanisms in epithelia. Am. J. Physiol. 275:C1391–
C1406.
Tominaga, M., T. Tominaga, A. Miwa, and Y. Okada. 1995. Volume-
sensitive chloride channel activity does not depend on endoge-
nous P-glycoprotein. J. Biol. Chem. 270:27887–27893.
Tsukita, S., M. Itoh, and S. Tsukita. 1989. A new 400-kD protein
from isolated adherens junctions: its localization at the under-
coat of adherens junctions and at microﬁlament bundles such as
stress ﬁbers and circumferential bundles. J Cell Biol. 108:31–41.
Tsumura, T., S. Oiki, S. Ueda, M. Okuma, and Y. Okada. 1996. Sen-
sitivity of volume-sensitive Cl2 conductance in human epithelial
cells to extracellular nucleotides. Am. J. Physiol. 271:C1872–
C1878.
Tsumura, T., A. Hazama, S. Ueda, and Y. Okada. 1998. Extracellular
ATP accelerates cell volume regulation after osmotic swelling in
human intestinal epithelial cells. Jpn. J. Physiol. 48:S108. (Abstr.)
Wang, Y., R. Roman, S.D. Lidofsky, and J.G. Fitz. 1996. Autocrine
signaling through ATP release represents a novel mechanism for
cell volume regulation. Proc. Natl. Acad. Sci. USA. 93:12020–
12025.
Watt, W.C., E.R. Lazarowski, and R.C. Boucher. 1998. Cystic ﬁbrosis
transmembrane regulator–independent release of ATP. Its impli-
cations for the regulation of P2Y2 receptors in airway epithelia. J.
Biol. Chem. 273:14053–14058.
Yada, T., S. Oiki, S. Ueda, and Y. Okada. 1989. Intestinal secreta-
gogues increase cytosolic free Ca21 concentration and K1 con-
ductance in a human intestinal epithelial cell line. J. Membr. Biol.
112:159–167.